{"rows":[{"id":6047,"title":"Psilocybin FCR Early-Stage Breast Cancer","authors":"NYU Langone Health","journal":"ClinicalTrials.gov","publication_date":"2026-11-02","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07909408","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-11-03 02:25:07","last_checked":"2026-11-03 02:25:07","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07909408","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07909408","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07909408","source_url":"https://clinicaltrials.gov/study/NCT07909408","doi":"","pmid":"","publication_date":"2026-11-02","importer_version":"2.1.3","text_redistributed":false}},{"id":6046,"title":"Furthering the Understanding of Psilocybin Use and Molecules Relevant to Depression and Schizophrenia.","authors":"Kalin NH.","journal":"The American journal of psychiatry","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1176/appi.ajp.20260960","pubmed_id":"42966738","openalex_id":"https://openalex.org/W7225051451","source_url":"https://doi.org/10.1176/appi.ajp.20260960","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-11-02 02:20:04","last_checked":"2026-11-03 02:20:20","bibtex":null,"source_record_id":"PMID:42966738","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42966738","source_url":"https://doi.org/10.1176/appi.ajp.20260960","doi":"10.1176/appi.ajp.20260960","pmid":"42966738","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":6039,"title":"Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial","authors":"Sayali, C.; Weisman, E.; Barrett, F. S.","journal":"medRxiv","publication_date":"2026-10-29","publication_year":2026,"doi":"10.64898/2026.10.27.26366630","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.10.27.26366630","substance_tags":"psilocybin","topic_tags":"Depression,Addiction","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-10-30 02:20:18","last_checked":"2026-11-03 02:20:58","bibtex":null,"source_record_id":"DOI:10.64898/2026.10.27.26366630","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.10.27.26366630","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.10.27.26366630","source_url":"https://doi.org/10.64898/2026.10.27.26366630","doi":"10.64898/2026.10.27.26366630","pmid":"","publication_date":"2026-10-29","importer_version":"2.1.3","text_redistributed":false}},{"id":6037,"title":"Psychedelic assisted psychotherapy (2020-2025): a scoping review of clinical evidence, mechanisms, safety, and ethics","authors":"Nasiru Mohammed Abdullahi, Rashid Menhas, Patience Osose Nasir, Mohamed Goda Elbqry, Fatma Mohamed Elmansy, Saddam Ahmed Al-Ahdal, Ashwaq Hamad Ali Alshmirry, Azza Elsayed Abd Elfatah Arafat, Samia Eaid Elgazzar, Fatima Sayed Osman Ashmieg","journal":"Frontiers in Psychology","publication_date":"2026-10-27","publication_year":2026,"doi":"10.3389/fpsyg.2026.1820860","pubmed_id":null,"openalex_id":"https://openalex.org/W7223781966","source_url":"https://doi.org/10.3389/fpsyg.2026.1820860","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Mechanism of Action,Consciousness,Spirituality,Clinical Trial,Randomized Controlled Trial,Review Article,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-29 02:20:17","last_checked":"2026-11-03 02:20:20","bibtex":null,"source_record_id":"DOI:10.3389/fpsyg.2026.1820860","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyg.2026.1820860","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3389/fpsyg.2026.1820860","source_url":"https://doi.org/10.3389/fpsyg.2026.1820860","doi":"10.3389/fpsyg.2026.1820860","pmid":"","publication_date":"2026-10-27","importer_version":"2.1.3","text_redistributed":false}},{"id":6035,"title":"High-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepis","authors":"Yao Sen, Liu Yuanyuan, Xia Weiwei, Xia Yue, Yang Kai, Li Hui, Xie Baogui","journal":"Journal of Fungi","publication_date":"2026-10-28","publication_year":2026,"doi":"10.3390/jof12110811","pubmed_id":null,"openalex_id":"https://openalex.org/W7224137409","source_url":"https://doi.org/10.3390/jof12110811","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Pharmacology,Mechanism of Action,Genomics,Transcriptomics","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-29 02:20:12","last_checked":"2026-11-03 02:20:20","bibtex":null,"source_record_id":"DOI:10.3390/jof12110811","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/jof12110811","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/jof12110811","source_url":"https://doi.org/10.3390/jof12110811","doi":"10.3390/jof12110811","pmid":"","publication_date":"2026-10-28","importer_version":"2.1.3","text_redistributed":false}},{"id":6033,"title":"Magic pathways: the genes and enzymes of psilocybin biosynthesis.","authors":"Worbs J, Schäfer T, Seibold PS, Blei F, Werten S, Rupp B, Hoffmeister D.","journal":"Microbiology and molecular biology reviews: MMBR","publication_date":"2026-10-27","publication_year":2026,"doi":"10.1128/mmbr.00117-25","pubmed_id":"42937360","openalex_id":null,"source_url":"https://doi.org/10.1128/mmbr.00117-25","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,In Vitro Study","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-28 02:20:05","last_checked":"2026-11-03 02:20:16","bibtex":null,"source_record_id":"PMID:42937360","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1128/mmbr.00117-25","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42937360","source_url":"https://doi.org/10.1128/mmbr.00117-25","doi":"10.1128/mmbr.00117-25","pmid":"42937360","publication_date":"2026-10-27","importer_version":"2.1.3","text_redistributed":false}},{"id":6032,"title":"Safety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among Veterans","authors":"VA Office of Research and Development","journal":"ClinicalTrials.gov","publication_date":"2026-10-26","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07895134","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-10-27 02:22:54","last_checked":"2026-11-02 02:23:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07895134","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07895134","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07895134","source_url":"https://clinicaltrials.gov/study/NCT07895134","doi":"","pmid":"","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6031,"title":"Substantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision Psychiatry","authors":"Inserra Antonio, Persico Luca, Rosati Arianna, Fabale Mara, Cavallotto Clara, D’Andrea Giacomo, Zoratto Francesca, Pettorruso Mauro, De Risio Luisa, Ventriglio Antonio, Bellomo Antonello, Nicolò Giuseppe, Martinotti Giovanni","journal":"Behavioral Sciences","publication_date":"2026-10-26","publication_year":2026,"doi":"10.3390/bs16111997","pubmed_id":null,"openalex_id":"https://openalex.org/W7223690592","source_url":"https://doi.org/10.3390/bs16111997","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-27 02:20:16","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"DOI:10.3390/bs16111997","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/bs16111997","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/bs16111997","source_url":"https://doi.org/10.3390/bs16111997","doi":"10.3390/bs16111997","pmid":"","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6030,"title":"Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.","authors":"Feifel D, Seynaeve M, Cubala WJ, Dunbar F, Gründer G, Dueñas Herrero RM, Hindocha C, Liknaitzky P, McGuigan SM, Mehta S, Pierce M, Repantis D, Roberts C, Wiegand F, Conley R.","journal":"JAMA","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1001/jama.2026.18380","pubmed_id":"42931733","openalex_id":"https://openalex.org/W7223694799","source_url":"https://doi.org/10.1001/jama.2026.18380","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"PMID:42931733","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1001/jama.2026.18380","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42931733","source_url":"https://doi.org/10.1001/jama.2026.18380","doi":"10.1001/jama.2026.18380","pmid":"42931733","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6029,"title":"Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis.","authors":"Frick A, Blest-Hopley G, Girn M, Erritzoe D, Nutt D, Carhart-Harris R.","journal":"Psychopharmacology","publication_date":"2026-10-26","publication_year":2026,"doi":"10.1007/s00213-026-07177-7","pubmed_id":"42931904","openalex_id":"https://openalex.org/W7223692295","source_url":"https://doi.org/10.1007/s00213-026-07177-7","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-27 02:20:04","last_checked":"2026-11-02 02:20:40","bibtex":null,"source_record_id":"PMID:42931904","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s00213-026-07177-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42931904","source_url":"https://doi.org/10.1007/s00213-026-07177-7","doi":"10.1007/s00213-026-07177-7","pmid":"42931904","publication_date":"2026-10-26","importer_version":"2.1.3","text_redistributed":false}},{"id":6027,"title":"Psilocybin and Clinical Depression","authors":"Richard Kensinger","journal":null,"publication_date":"2026-10-23","publication_year":2026,"doi":"10.13140/rg.2.2.36134.89921","pubmed_id":null,"openalex_id":"https://openalex.org/W7223284694","source_url":"https://doi.org/10.13140/rg.2.2.36134.89921","substance_tags":"psilocybin","topic_tags":"Depression,Spirituality","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-25 02:20:27","last_checked":"2026-10-30 02:20:22","bibtex":null,"source_record_id":"DOI:10.13140/rg.2.2.36134.89921","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.13140/rg.2.2.36134.89921","source_url":"https://doi.org/10.13140/rg.2.2.36134.89921","doi":"10.13140/rg.2.2.36134.89921","pmid":"","publication_date":"2026-10-23","importer_version":"2.1.3","text_redistributed":false}},{"id":6025,"title":"Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence.","authors":"Kaczmarek ES, Wong S, Chisamore N, Stern M, Doyle Z, Johnson DE, McIntyre RS, Rosenblat JD.","journal":"Journal of psychiatric research","publication_date":"2026-10-19","publication_year":2026,"doi":"10.1016/j.jpsychires.2026.10.023","pubmed_id":"42906286","openalex_id":null,"source_url":"https://doi.org/10.1016/j.jpsychires.2026.10.023","substance_tags":"psilocybin","topic_tags":"Depression,Aging,Clinical Trial,Systematic Review,Review Article,Animal Study","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-24 01:20:06","last_checked":"2026-10-26 02:20:18","bibtex":null,"source_record_id":"PMID:42906286","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.jpsychires.2026.10.023","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42906286","source_url":"https://doi.org/10.1016/j.jpsychires.2026.10.023","doi":"10.1016/j.jpsychires.2026.10.023","pmid":"42906286","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}},{"id":6021,"title":"Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial.","authors":"Bradley ER, Kelley P, Szigeti B, Nishimi K, Picard M, Sakai K, Fernandes-Osterhold G, Ostrem JL, Tanner CM, Ludwig C, Llerena K, Finley PR, Busby Z, McKernan A, Pantoni MM, Penn AD, Wang ACC, Zuzuarregui JRP, Woolley JD, O'Donovan A.","journal":"JAMA psychiatry","publication_date":"2026-10-21","publication_year":2026,"doi":"10.1001/jamapsychiatry.2026.2733","pubmed_id":"42905733","openalex_id":"https://openalex.org/W7223091331","source_url":"https://doi.org/10.1001/jamapsychiatry.2026.2733","substance_tags":"psilocybin","topic_tags":"Biomarkers,Mitochondrial Function,Clinical Trial,Inflammation","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-22 01:20:21","last_checked":"2026-10-28 02:20:28","bibtex":null,"source_record_id":"PMID:42905733","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1001/jamapsychiatry.2026.2733","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42905733","source_url":"https://doi.org/10.1001/jamapsychiatry.2026.2733","doi":"10.1001/jamapsychiatry.2026.2733","pmid":"42905733","publication_date":"2026-10-21","importer_version":"2.1.3","text_redistributed":false}},{"id":6020,"title":"Connectedness as a mechanism of change in psilocybin-assisted cognitive behavioral therapy for major depressive disorder","authors":"Lorenzo A. Miller, Cordelia Kuiper-Rauch, Keren Chen, NICHOLAS J. JACKSON, David J. Miklowitz, Marc J. Weintraub","journal":"Psychedelics","publication_date":"2026-10-14","publication_year":2026,"doi":"10.1016/j.psyche.2026.100044","pubmed_id":null,"openalex_id":"https://openalex.org/W7221795368","source_url":"https://doi.org/10.1016/j.psyche.2026.100044","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-21 01:20:18","last_checked":"2026-10-21 01:20:18","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100044","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100044","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100044","source_url":"https://doi.org/10.1016/j.psyche.2026.100044","doi":"10.1016/j.psyche.2026.100044","pmid":"","publication_date":"2026-10-14","importer_version":"2.1.3","text_redistributed":false}},{"id":6018,"title":"Clinical Evidence on Psilocybin and Its Representation in Media Reporting","authors":"Madden Kim, Flood Breanne, Kashir Imad, Ahmad Rayan, Ali Hiba, Petranker Rotem, MacKillop James, Adili Anthony","journal":"JAMA Network Open","publication_date":"2026-10-20","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.38843","pubmed_id":"42900476","openalex_id":"https://openalex.org/W7223031286","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.38843","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Headache / Migraine,Aging,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-10-21 01:20:14","last_checked":"2026-10-27 02:20:21","bibtex":null,"source_record_id":"PMID:42900476","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.38843","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42900476","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.38843","doi":"10.1001/jamanetworkopen.2026.38843","pmid":"42900476","publication_date":"2026-10-20","importer_version":"2.1.3","text_redistributed":false}},{"id":6017,"title":"From Altered States to Fundamental Peace: Taxonomies of Consciousness, Psychedelics and Hypnosis Through the Lens of the Yoga Vāsiṣṭha","authors":"Luis Miguel Gallardo","journal":null,"publication_date":"2026-10-18","publication_year":2026,"doi":"10.68220/whf.2026.007","pubmed_id":null,"openalex_id":"https://openalex.org/W7222864490","source_url":"https://doi.org/10.68220/whf.2026.007","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Default Mode Network,Consciousness,Emotional Processing,Mystical Experience,Meta-Analysis,Review Article,Treatment-Resistant Depression","study_type":"Meta-Analysis","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-20 01:20:21","last_checked":"2026-10-25 02:20:27","bibtex":null,"source_record_id":"DOI:10.68220/whf.2026.007","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.68220/whf.2026.007","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.68220/whf.2026.007","source_url":"https://doi.org/10.68220/whf.2026.007","doi":"10.68220/whf.2026.007","pmid":"","publication_date":"2026-10-18","importer_version":"2.1.3","text_redistributed":false}},{"id":6016,"title":"Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability","authors":"Szarpak Lukasz, Pruc Michal, Jablonska-Moczulo Dorota, Niewiadomska Iwona, Rybczynski Bernard, Cubała Wiesław J.","journal":"Therapeutics","publication_date":"2026-10-19","publication_year":2026,"doi":"10.3390/therapeutics3040021","pubmed_id":null,"openalex_id":"https://openalex.org/W7222918595","source_url":"https://doi.org/10.3390/therapeutics3040021","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Meta-Analysis,Review Article,Treatment-Resistant Depression,Safety","study_type":"Meta-Analysis","source_name":"Crossref","publication_status":"published","date_added":"2026-10-20 01:20:16","last_checked":"2026-10-26 02:20:23","bibtex":null,"source_record_id":"DOI:10.3390/therapeutics3040021","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/therapeutics3040021","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/therapeutics3040021","source_url":"https://doi.org/10.3390/therapeutics3040021","doi":"10.3390/therapeutics3040021","pmid":"","publication_date":"2026-10-19","importer_version":"2.1.3","text_redistributed":false}},{"id":6015,"title":"Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways.","authors":"Chaudhary S, Dhankhar S, Saini M, Singh TG, Chauhan S, Kumar V.","journal":"CNS & neurological disorders drug targets","publication_date":"2026-10-14","publication_year":2026,"doi":"10.2174/0118715273491538261009064612","pubmed_id":"42895147","openalex_id":"https://openalex.org/W7222979533","source_url":"https://doi.org/10.2174/0118715273491538261009064612","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,OCD,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Randomized Controlled Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Inflammation","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-20 01:20:06","last_checked":"2026-10-21 01:20:19","bibtex":null,"source_record_id":"PMID:42895147","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/0118715273491538261009064612","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42895147","source_url":"https://doi.org/10.2174/0118715273491538261009064612","doi":"10.2174/0118715273491538261009064612","pmid":"42895147","publication_date":"2026-10-14","importer_version":"2.1.3","text_redistributed":false}},{"id":6014,"title":"The Hidden Therapeutic Bridge: Exploring Psilocybin's Role in Depression, Inflammation, and Pain - A Narrative Review.","authors":"Vazquez-Barreto M, Ugarte-Rocha M, Flores Vargas A, García Núñez YA, Hahn D, Coffeen U.","journal":"Current neuropharmacology","publication_date":"2026-10-14","publication_year":2026,"doi":"10.2174/011570159x513731260923101459","pubmed_id":"42895152","openalex_id":null,"source_url":"https://doi.org/10.2174/011570159x513731260923101459","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Chronic Pain,Mechanism of Action,Default Mode Network,Mystical Experience,Review Article,Inflammation","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-20 01:20:06","last_checked":"2026-10-21 01:20:15","bibtex":null,"source_record_id":"PMID:42895152","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/011570159x513731260923101459","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42895152","source_url":"https://doi.org/10.2174/011570159x513731260923101459","doi":"10.2174/011570159x513731260923101459","pmid":"42895152","publication_date":"2026-10-14","importer_version":"2.1.3","text_redistributed":false}},{"id":6011,"title":"Adverse outcomes of psychedelics self-reported: Survey","authors":"Alison Knopf","journal":"Alcoholism & Drug Abuse Weekly","publication_date":"2026-10-16","publication_year":2026,"doi":"10.1002/adaw.35083","pubmed_id":null,"openalex_id":"https://openalex.org/W7222604653","source_url":"https://doi.org/10.1002/adaw.35083","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Observational Study,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-18 01:20:26","last_checked":"2026-10-23 01:20:34","bibtex":null,"source_record_id":"DOI:10.1002/adaw.35083","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/adaw.35083","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/adaw.35083","source_url":"https://doi.org/10.1002/adaw.35083","doi":"10.1002/adaw.35083","pmid":"","publication_date":"2026-10-16","importer_version":"2.1.3","text_redistributed":false}}],"total":1708,"page":1,"per_page":20,"pages":86,"resource":"papers","filters":{"notification":null,"q":"depression","author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}